Your browser doesn't support javascript.
loading
A thematic analysis of MDMA-related harm and harm reduction experiences and knowledge in Aotearoa New Zealand.
Whelan, Jai; Ward, Ryan D; Noller, Geoff.
Afiliación
  • Whelan J; Department of Psychology, University of Otago, William James Building, Level 1, 275 Leith Walk, Otepoti/Dunedin, Aotearoa, 9016, New Zealand. jai.whelan@postgrad.otago.ac.nz.
  • Ward RD; Department of Psychology, University of Otago, William James Building, Level 1, 275 Leith Walk, Otepoti/Dunedin, Aotearoa, 9016, New Zealand.
  • Noller G; Department of General Practice and Rural Health, Dunedin School of Medicine, University of Otago, Otepoti/Dunedin, Aotearoa, New Zealand.
Harm Reduct J ; 21(1): 100, 2024 May 23.
Article en En | MEDLINE | ID: mdl-38783300
ABSTRACT

BACKGROUND:

Methylenedioxymethamphetamine (MDMA) is a popular drug worldwide and use is prevalent in Aotearoa New Zealand. Although associated with some significant harms, including fatalities, MDMA is ultimately less harmful than other commonly consumed drugs. We aimed to expand the understanding of MDMA harm and harm reduction strategies from a consumer perspective so that national harm reduction efforts can be better informed.

METHODS:

We conducted 14 semi-structured focus group discussions including 60 people (aged 18-67, median = 21) who use MDMA in the Southern region of Aotearoa New Zealand to explore their thoughts and experiences regarding MDMA associated harm and harm reduction. Reflexive thematic analysis was conducted from a critical realist perspective.

RESULTS:

Five themes were generated; (1) Mindset and setting matters; (2) Looking after your body and mind, not overdoing it; (3) Other substances increase risk and harm; (4) Trusted friends and peers are protective; and (5) Valid information is key for healthy self-determination; and one subtheme 5.1) Drug checking is essential harm reduction.

CONCLUSIONS:

We discuss the implications for MDMA consumers and aim to inform national drug policy and the harm reduction practices of consumers and organisations, for the ultimate purpose of reducing MDMA-related harm in Aotearoa New Zealand.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: N-Metil-3,4-metilenodioxianfetamina / Reducción del Daño Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Harm Reduct J Año: 2024 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: N-Metil-3,4-metilenodioxianfetamina / Reducción del Daño Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Harm Reduct J Año: 2024 Tipo del documento: Article País de afiliación: Nueva Zelanda